Zika Vaccine Will Provide Case Study For Future Public-Private Partnerships
Pharma & Healthcare / United States / Fri 08 Sep, 2017
Sanofi Pasteur maintains that a public-private partnership approach over the Zika public health emergency was the right course to take, but, given the considerable opposition over the firm's exclusive licence to patents developed through public funds, this has proved to be a useful case study for managing such contracts in the future. Companies